Elevated Concentration of Defensins in Hepatitis C Virus-Infected Patients

Table 4

Comparison between total, α-, and -defensin concentration level in HCV patients serum.

Variables	Concentration (ng/50 μL)
	Gender		Total defensin	-defensin	-defensin
Health sample	6 M, 6 F	12	18.66 ± 3.5	13.5 ± 1.2	2.88 ± 0.14
STD 31.2	Standard	2	31.2	31.2	31.2
STD 62.5	Standard	2	62.5	62.5	62.5
STD 125	Standard	2	125	125	125
STD 250	Standard	2	250	250	250
STD 500	Standard	2	500	500	500
STD 1000	Standard	2	1000	1000	1000
Sample 1	M	4	37.44	31.3	45.45
Sample 2	M	4	867.701	31.2	379.9
Sample 3	F	4	1852.60	512.83	1056.11
Sample 4	F	4	103.58	31.3	86.2
Sample 5	M	4	1611.68	1398.03	776.15
Sample 6	M	4	47.43	31.2	55.70
Sample 7	F	4	1070.64	1180.5	843.97
Sample 8	M	4	69.04	206.44	81.6
Sample 9	M	4	100.30	31.2	155.7
Sample 10	F	4	86.96	31.2	51.53
Sample 11	M	4	1979.180	1063.15	56.35
Sample 12	M	4	100.93	31.6	111.44
Sample 13	F	4	51.33	31.3	102.8
Sample 14	M	4	226.66	56.3	207.5
Sample 15	M	4	987.91	190.11	634.95
Sample 16	F	4	380	164.9	394.31
Sample 17	F	4	1587.99	918.31	101.1
Sample 18	F	4	242.02	121.9	105.33
Sample 19	M	4	138.7	72.32	44.51
Sample 20	F	4	358.5	184.21	390.9
Sample 21	M	4	329.53	62.3	64.33
Sample 22	M	4	165.4	131.81	91.77
Sample 23	M	4	39.50	31.3	688.01
Sample 24	F	4	251.78	77.32	258.0
Sample 25	F	4	209.74	101.8	687.71
Sample 26	M	4	472.5	92.4	686.2
Sample 27	M	4	189.25	33.60	55.5
Sample 28	M	4	60.41	108.51	370.9
Sample 29	F	4	186.16	31.3	322.1
Sample 30	M	4	115.51	31.3	770.97
Sample 31	M	4	202.5	66.31	461.3
Sample 32	F	4	45.15	31.2	108.95
Sample 33	F	4	212.71	31.3	793.23
Sample 34	F	4	104.22	65.10	258.26